Literature DB >> 4004808

Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine.

J S Hunt, A R McGiven, A Groufsky, K L Lynn, M C Taylor.   

Abstract

Rabbit antibodies to human Tamm-Horsfall glycoprotein (prepared by salt precipitation from normal urine) were purified by affinity chromatography using columns containing Tamm-Horsfall glycoprotein linked to CNBr-activated Sepharose 4B. The specificity of these antibodies was determined by analysis of their binding characteristics on Western blots of Tamm-Horsfall protein from sodium dodecyl sulphate/polyacrylamide gradient gels and comparison with the reactivity of monoclonal antibodies to this glycoprotein. Optimal conditions of adsorption to poly(vinyl chloride) microtitre plates were established such that these purified antibodies could be used in a solid-phase radioimmunoassay for the determination of urinary Tamm-Horsfall-glycoprotein concentration. The specificity of the immunoassay was confirmed by competitive inhibition of the urinary Tamm-Horsfall glycoprotein by purified freeze-dried material in solution. A standard curve obtained with this material showed the radioimmunoassay to have a sensitivity of at least 5 ng/ml, with linearity between 30 and 600 ng/ml. The mean coefficient of variation over the linear section of the curve was 11.3 +/- 2.2% (n = 13). The effects of dialysis and freezing of urine samples before determination of Tamm-Horsfall-glycoprotein concentrations were investigated and the mean 24 h urinary excretion rate in 60 normal donors was shown to be 84.9 +/- 44.1 mg.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004808      PMCID: PMC1144927          DOI: 10.1042/bj2270957

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Determination of the Tamm and Horsfall glycoprotein in human urine.

Authors:  J Wieslander; P Bygren; D Heinegård
Journal:  Clin Chim Acta       Date:  1977-08-01       Impact factor: 3.786

2.  The nature of urinary casts.

Authors:  E G McQueen
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Tamm-Horsfall protein in the glomerular capsular space.

Authors:  A R McGiven; J S Hunt; W A Day; R R Bailey
Journal:  J Clin Pathol       Date:  1978-07       Impact factor: 3.411

4.  Tamm-Horsfall glycoprotein: ultrastructural immunoperoxidase localization in rat kidney.

Authors:  J R Hoyer; S P Sisson; R L Vernier
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

5.  Pathophysiology of Tamm-Horsfall protein.

Authors:  J R Hoyer; M W Seiler
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

6.  Tamm-Horsfall urinary glycoprotein quantitation by radial immunodiffusion: normal patterns.

Authors:  N Mazzuchi; R Pecarovich; N Ross; I Rodríguez; C M Sanguinetti
Journal:  J Lab Clin Med       Date:  1974-11

7.  The development of a radioimmunoassay for the measurement of urinary Tamm-Horsfall glycoprotein in the presence of sodium dodecyl sulphate.

Authors:  A M Grant; A Neuberger
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  The presence in serum of proteins which are immunologically cross-reactive with Tamm-Horsfall glycoprotein.

Authors:  K L Lynn; R D Marshall
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

10.  An improved radioimmunoassay for urinary Tamm-Horsfall glycoprotein. Investigation and resolution of factors affecting its quantification.

Authors:  A B Dawnay; C Thornley; W R Cattell
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

View more
  10 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury.

Authors:  Nining Hsieh; Ching-Hua Shih; Huey-Yi Chen; Mei-Chen Wu; Wen-Chi Chen; Chia-Wei Li
Journal:  Urol Res       Date:  2003-02-12

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies.

Authors:  S Kumar; B Jasani; J S Hunt; D B Moffat; A W Asscher
Journal:  Histochem J       Date:  1985-11

5.  Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy.

Authors:  R J Peach; W A Day; P J Ellingsen; A R McGiven
Journal:  Histochem J       Date:  1988-03

6.  Study of childhood renal tumours using a monoclonal antibody to Tamm-Horsfall protein.

Authors:  S Kumar; H B Marsden; B Jasani; P Kumar
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

7.  OCH1 encodes a novel membrane bound mannosyltransferase: outer chain elongation of asparagine-linked oligosaccharides.

Authors:  K Nakayama; T Nagasu; Y Shimma; J Kuromitsu; Y Jigami
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

8.  Goat uromodulin promoter directs kidney-specific expression of GFP gene in transgenic mice.

Authors:  Yue-Jin Huang; Nathalie Chretien; Annie S Bilodeau; Jiang Feng Zhou; Anthoula Lazaris; Costas N Karatzas
Journal:  BMC Biotechnol       Date:  2005-04-11       Impact factor: 2.563

Review 9.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

10.  Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation.

Authors:  Diana C J Rhodes
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.